ALKS vs SPGI · P/E 14, rev $1.56B vs P/E 27, rev $15.34B
Alkermes Plc (ALKS) versus S&P Global Inc (SPGI) — a side-by-side from cached financials, not a winner call.
Alkermes Plc (ALKS) is a drug manufacturers - specialty & generic company listed on US.
S&P Global Inc (SPGI) is a financial data & stock exchanges company listed on NYSE.
Latest reported ALKS revenue for 2024-12-31 was $1.56B. Net income was $367.1M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. ALKS currently screens at market cap $4.78B and trailing P/E 13.8.
Latest reported SPGI revenue for 2025-12-31 was $15.34B. Net income was $4.47B. Revenue was up 7.9% from 2024-12-31 to 2025-12-31. SPGI currently screens at market cap $127.50B and trailing P/E 27.2.
ALKS currently screens at market cap $4.78B and trailing P/E 13.8. SPGI currently screens at market cap $127.50B and trailing P/E 27.2.
Not investment advice. Open the ALKS and SPGI stock pages for the full models.
Not investment advice.